RKL Wealth Management LLC Has $961,000 Position in Colgate-Palmolive (CL)
RKL Wealth Management LLC boosted its position in shares of Colgate-Palmolive (NYSE:CL) by 8.3% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 12,743 shares of the company’s stock after purchasing an additional 973 shares during the quarter. RKL Wealth Management LLC’s holdings in Colgate-Palmolive were worth $961,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors have also recently modified their holdings of the stock. Vanguard Group Inc. boosted its holdings in shares of Colgate-Palmolive by 2.4% in the second quarter. Vanguard Group Inc. now owns 67,875,384 shares of the company’s stock valued at $5,031,602,000 after buying an additional 1,621,392 shares during the period. Renaissance Technologies LLC boosted its holdings in shares of Colgate-Palmolive by 42.4% in the second quarter. Renaissance Technologies LLC now owns 9,753,400 shares of the company’s stock valued at $723,020,000 after buying an additional 2,903,800 shares during the period. Arrowstreet Capital Limited Partnership boosted its holdings in shares of Colgate-Palmolive by 25.3% in the second quarter. Arrowstreet Capital Limited Partnership now owns 6,854,323 shares of the company’s stock valued at $508,111,000 after buying an additional 1,385,946 shares during the period. First Eagle Investment Management LLC boosted its holdings in shares of Colgate-Palmolive by 35.8% in the third quarter. First Eagle Investment Management LLC now owns 6,641,548 shares of the company’s stock valued at $483,837,000 after buying an additional 1,750,417 shares during the period. Finally, APG Asset Management N.V. boosted its holdings in shares of Colgate-Palmolive by 33.2% in the fourth quarter. APG Asset Management N.V. now owns 5,421,184 shares of the company’s stock valued at $340,630,000 after buying an additional 1,350,400 shares during the period. Hedge funds and other institutional investors own 72.85% of the company’s stock.
Shares of Colgate-Palmolive (NYSE CL) opened at $70.19 on Tuesday. The company has a quick ratio of 0.34, a current ratio of 0.47 and a debt-to-equity ratio of 24.42. The company has a market cap of $61,256.62, a price-to-earnings ratio of 24.31, a PEG ratio of 2.58 and a beta of 0.75. Colgate-Palmolive has a 1 year low of $67.19 and a 1 year high of $77.91.
The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, February 15th. Stockholders of record on Tuesday, January 23rd will be given a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a dividend yield of 2.28%. The ex-dividend date is Monday, January 22nd. Colgate-Palmolive’s dividend payout ratio is presently 70.18%.
In other Colgate-Palmolive news, insider Jennifer Daniels sold 902 shares of the company’s stock in a transaction on Tuesday, January 9th. The shares were sold at an average price of $75.82, for a total transaction of $68,389.64. Following the sale, the insider now directly owns 37,788 shares of the company’s stock, valued at $2,865,086.16. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, VP Henning I. Jakobsen sold 36,215 shares of the company’s stock in a transaction on Monday, February 5th. The stock was sold at an average price of $71.22, for a total transaction of $2,579,232.30. Following the sale, the vice president now directly owns 70,783 shares in the company, valued at $5,041,165.26. The disclosure for this sale can be found here. In the last three months, insiders sold 318,451 shares of company stock worth $22,874,017. 1.02% of the stock is currently owned by insiders.
Several research analysts have recently weighed in on CL shares. Citigroup reduced their price target on shares of Colgate-Palmolive from $76.00 to $75.00 and set a “neutral” rating for the company in a report on Thursday, November 2nd. Zacks Investment Research upgraded shares of Colgate-Palmolive from a “hold” rating to a “buy” rating and set a $81.00 price target for the company in a report on Monday, October 23rd. KeyCorp reiterated a “hold” rating on shares of Colgate-Palmolive in a report on Saturday, November 25th. Macquarie upgraded shares of Colgate-Palmolive from a “neutral” rating to an “outperform” rating and set a $81.00 price target for the company in a report on Tuesday, December 19th. Finally, Stifel Nicolaus set a $73.00 price target on shares of Colgate-Palmolive and gave the company a “hold” rating in a report on Sunday, October 29th. Three equities research analysts have rated the stock with a sell rating, eleven have given a hold rating and five have given a buy rating to the company. The stock presently has a consensus rating of “Hold” and a consensus price target of $77.71.
Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.